Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 6Central Nervous System Neoplasms 5Gliosarcoma 4Brain Neoplasms 4Glioma 3Astrocytoma 3Oligodendroglioma 2Medulloblastoma 2Glioma, Subependymal 2Ependymoma 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Sarcoma 1Rhabdoid Tumor 1Pyloric Stenosis, Hypertrophic 1Pinealoma 1Pheochromocytoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Liver Neoplasms 1Head and Neck Neoplasms 1Familial ependymoma 1Disease Progression 1Carcinoma, Medullary 1Carcinoma, Hepatocellular 1

Interventions

vandetanib 2Bevacizumab 2Anthropogenic Effects 2enzastaurin 1carotuximab 1Temozolomide 1Tamoxifen 1Steroids 1Irinotecan 1Carboplatin 1Bortezomib 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Progression × Tamoxifen × CNS × Clear all
NCT00108069 2015-11-05

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
43 enrolled 11 charts
CNS

Brain Neoplasms, Glioma, Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡